Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.544,77
0,09%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSX Numinus Wellness Inc (NUMI) Numinus Wellness Inc (NUMI) Notizie

NUMI

Numinus Wellness (NUMI)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSX:NUMI
DataOraFonteTitoloSimboloCompagnia
01/06/202401:38PR Newswire (US)Numinus Wellness Announces Voting Results From its Annual General Meeting of ShareholdersTSX:NUMINuminus Wellness Inc
30/05/202413:00PR Newswire (US)Numinus Wellness Receives Health Canada Approval for Study into Group Model for MDMA-Assisted TherapyTSX:NUMINuminus Wellness Inc
07/05/202413:00PR Newswire (Canada)Numinus Wellness Focused on Boosting Profitability and Expanding Community SupportTSX:NUMINuminus Wellness Inc
17/04/202413:00PR Newswire (US)Cedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003TSX:NUMINuminus Wellness Inc
15/04/202413:41PR Newswire (US)Numinus Wellness Provides Corporate UpdateTSX:NUMINuminus Wellness Inc
13/04/202401:49PR Newswire (Canada)Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 ResultsTSX:NUMINuminus Wellness Inc
09/04/202413:00PR Newswire (US)Numinus to Host Q2 Fiscal 2024 Results Conference Call on April 15, 2024TSX:NUMINuminus Wellness Inc
20/03/202412:00PR Newswire (US)Numinus Wellness Submits Clinical Trial ApplicationTSX:NUMINuminus Wellness Inc
08/03/202413:00PR Newswire (Canada)Numinus Wellness Congratulates MindMed on Positive Results from Phase 2B Clinical Trials of MM120 for Generalized Anxiety DisorderTSX:NUMINuminus Wellness Inc
16/02/202416:29PR Newswire (Canada)Numinus Wellness Inc. Closes $6 Million Bought Deal Public OfferingTSX:NUMINuminus Wellness Inc
14/02/202416:39PR Newswire (Canada)Numinus Wellness Inc. Congratulates Lykos Therapeutics on FDA Acceptance of New Drug Application for MDMA-Assisted Therapy for PTSDTSX:NUMINuminus Wellness Inc
02/02/202414:07PR Newswire (Canada)L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - NUMITSX:NUMINuminus Wellness Inc
02/02/202414:06PR Newswire (Canada)Canadian Investment Regulatory Organization Trade Resumption - NUMITSX:NUMINuminus Wellness Inc
01/02/202422:50PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - NUMITSX:NUMINuminus Wellness Inc
01/02/202422:41PR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - NUMITSX:NUMINuminus Wellness Inc
01/02/202420:59PR Newswire (US)/C O R R E C T I O N from Source -- Numinus Wellness Inc./TSX:NUMINuminus Wellness Inc
01/02/202413:00PR Newswire (US)Numinus Wellness Divests of Holdings in Alto Neuroscience Inc.TSX:NUMINuminus Wellness Inc
15/01/202423:00PR Newswire (US)Numinus Wellness Inc. Announces First Quarter Fiscal 2024 ResultsTSX:NUMINuminus Wellness Inc
02/01/202423:00PR Newswire (US)Numinus to Host Q1 Fiscal 2024 Results Conference Call on January 15, 2024TSX:NUMINuminus Wellness Inc
15/12/202316:26PR Newswire (US)Cedar Clinical Research selected as clinical research site for Beckley Psytech's Phase 2b StudyTSX:NUMINuminus Wellness Inc
13/12/202313:00PR Newswire (US)Numinus Congratulates MAPS on its Application to the FDA for MDMA-Assisted Therapy for PTSDTSX:NUMINuminus Wellness Inc
29/11/202323:00PR Newswire (US)Numinus Wellness Inc. Announces Fourth Quarter and Full Year Fiscal 2023 ResultsTSX:NUMINuminus Wellness Inc
21/11/202314:00PR Newswire (US)Numinus to Host Q4 2023 and Annual Results Conference Call on November 29, 2023TSX:NUMINuminus Wellness Inc
03/10/202313:00PR Newswire (US)Numinus Announces Psychedelic Program for Mental Distress Associated with Chronic and Serious Illness through Cedar Clinical ResearchTSX:NUMINuminus Wellness Inc
26/09/202301:16PR Newswire (Canada)Numinus Wellness Inc. Announces At-The-Market Offering Equity ProgramTSX:NUMINuminus Wellness Inc
19/09/202313:00PR Newswire (US)Numinus Congratulates MAPS on its Phase 3 Study Results Published in Nature MedicineTSX:NUMINuminus Wellness Inc
19/09/202300:45PR Newswire (US)Numinus Takes Actions to Accelerate its Path to Profitability by Focusing on Positive Cash Flow Generating OperationsTSX:NUMINuminus Wellness Inc
09/08/202313:00PR Newswire (US)Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, August 17, 2023TSX:NUMINuminus Wellness Inc
17/07/202322:01PR Newswire (US)Numinus Wellness Inc. Reports Q3 2023 ResultsTSX:NUMINuminus Wellness Inc
11/07/202300:29PR Newswire (Canada)Numinus to Present at the Small Cap Growth Virtual Investor Conference on July 13, 2023TSX:NUMINuminus Wellness Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSX:NUMI

La tua Cronologia

EU
4416T
4416T
COIN
FETKRW
Fetch
USOTC
SKURF
Sakura Internet (PK)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network